Article thumbnail

The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment?

By Norbert Gleicher, Andrea Weghofer and David H Barad
Topics: Review
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2010). A: Addition of dehydroepiandrosterone (DHEA) for poor-respoder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study. Hum Reprod
  2. A: Correlation between functional ovarian reserve, assessed by anti-Müllerian hormone (AMH), and oocyte numbers, based on FMR1 genotypes and sub-genotypes: The hom sub-genotypes. Fertil Steril ,
  3. (2009). A: Testosterone and dehydroepiandrosterone sulfate levels and IVF/ICSI results. Gynecol Endocrin
  4. (2004). AB: Effects of dehydroepiandrosterone on ovarian cystogenesis and immune function.
  5. (2010). AB: Hyperandrogenism alters intraovarian parameters during early folliculogenesis in mice. Reprod Biomed Online
  6. (2008). AN: Short-term androgen priming with use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial. Hum Reprod
  7. (2009). Androgen circle of polycystic ovary syndrome. Hum Reprod
  8. (2006). Androgen priming using aromatase inhibitor and hCG during earlyfollicular phase GnRH antagonist down-regulation in modified antagonist protocol. Hum Reprod
  9. Barad DH: Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR). Reprod Biol Endocrin .
  10. (2007). Barad DH: Gender as a risk factor for autoimmune diseases.
  11. (1998). CA: Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations.
  12. (2008). Carr BR: Oocyte quality in adult polycystic ovary syndrome. Semin Reprod Med
  13. (2011). Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity.
  14. (2003). Coutifaris C: In vitro fertilization in the PCOS patient: clinical considerations. Semin Reprod Med
  15. (2008). Cytological and expression studies and quantitative analysis of the temporal and stage-specific effects of follicle-stimulating hormone and testosterone during cocultures of the normal human seminiferous epithelium. Biol Reprod
  16. (2008). De Sutter P: Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome. Gynecol Endocrinol
  17. (2010). DH: Anti-Müllerian hormone (AMH) defines, independent of age, low versus good live birth chances in women with severely diminished ovarian reserve. Fertil Steril
  18. DH: Association of FMR1 genotypes with in vitro fertilization (IVF) outcomes based on ethnicity/race.
  19. (2011). DH: Defining ovarian reserve to better understand ovarian aging. Reprod Biol Endocrinol
  20. (2010). DH: Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS). Reprod Biol Endocrinol
  21. (2010). DH: FMR1 genotype with autoimmunity-associated polycystic ovary-like phenotype and decrease pregnancy chance. PLoS ONE
  22. (2010). DH: Improvement in diminished ovarian reserve after dehydroepiandrosterone supplementation. Reprod Biomed Online
  23. (2009). DH: Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study. Reprod Biol Endocinol
  24. (2007). DH: Polycystic ovary syndrome and oocyte development competence. Obstet Gynecol Surv
  25. (2010). Different follicle-stimulating hormone exposure regimens during antral follicle growth alter gene expression in the cumulus-oocyte complex in mice. Biol Reprod
  26. (2007). Differential actions of FSH and LH during folliculogenesis. Reprod Biomed Online
  27. (2006). Effect of dehydroepiandrosterone on oocyte and embryo yields, embyo grade and cell number in IVF. Hum Reprod
  28. (1998). Effects of dose of LH on androgen production and luteinization of ovine theca cells cultured in serum-free system.
  29. (2006). Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproductive-technique - a prospective randomized, double blind study. Hum Reprod
  30. (1983). Eppig JJ: Regulation of oocyte maturatation in the mouse: possible roles of intercellular communication, cAMP, and testosterone. Dev Biol
  31. (2010). Exposing cultured mouse ovarian follicles under increased gonadotropin tonus to aromatizable androgens influences the steroid balance and reduces oocyte meiotic capacity. Endocrine
  32. (2006). Fauser BC: A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum Reprod Update
  33. (2010). Feng HL: Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update
  34. (2010). FJ: Molecular insights into androgen actions in male and female reproductive function from androgen receptor knockout models. Hum Reprod Update
  35. (2008). Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update
  36. (2006). Fortune JE: Testosterone stimulates the primary to secondary follicle transition in bovine follicles in vitro. Biol Reprod
  37. (2009). Functional AR signaling is evident in an in vitro mouse follicle culture bioassay that encompasses most stages of folliculogenesis. Biol Reprod
  38. (2008). Gersak K: Androgen receptor gene (CAG)n polymorphism in patients with polycystic ovary syndrome. Fertil Steril
  39. (2011). Gershwine ME: Drug-induced lupus erythematosus: incidence, management and prevention. Drug Saf
  40. (2009). Glucocorticoid or androgen for autoimmune premature ovary failure in mice. Zhong Nan Da Xue Xue Bao Yi Xue Ban
  41. (1991). GY: Changes in ovarian morphology and serum hormones in the rat after treatment with dehydroepiandrosterone. Anat Rec
  42. (2011). H-A: The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders. Fertil Steril
  43. (2010). Hammes SR: Granulosa-cell specific androgen receptors are critical regulators of ovarian development and function. Mol Endocrinol
  44. (2003). Hammes SR: Selective modulation of genomic and nongenomic androgen responses by androgen receptor ligands. Mol Endocrinol
  45. (2005). Hammes SR: Specific modulation of nongenomic androgen signaling in the ovary. Steroids
  46. (2009). Handelsman DJ: Subfertile female androgen receptor knockout mice exhibit defects in neuroendocrine signaling, intraovarian function, and uterine development but not uterine function. Endocrinology
  47. (2008). HD: Testosterone selectively increases primary follicles in ovarian cortex grafted onto embryonic chick membranes: relevance to polycystic ovaries. Reproduction
  48. (1997). HM: Androgen receptor function in folliculogenesis and its clinical implication in premature ovarian failure. Hum Reprod
  49. (2005). Increased oocyte production after treatment with dehydroepiandrosterone. Fertil Steril
  50. (1983). Inhibition of oocyte maturation in the mouse: participation of cAMP, steroid hormone, and a putative maturation-inhibitory factor. Dev Biol
  51. (2000). JE: Dehydroepiandrosterone aupplementation augments ovarian stimulation in poor responders; a case series. Hum Reprod
  52. (1996). JE: Ovarian hyperstimulation augments adrenal dehydroepiandrosterone sulfate secretion. Fertil Steril
  53. (1998). JE: Postmenopausal DHEA administration increases free insulinlike growth factor - I and decreases high-density lipoprotein: a sixmonth trial. Fertil Steril
  54. (2007). Lack of association between polycystic ovary syndrome and embryonic aneuploidy. Fertil Steril
  55. (1997). Lessing JB: Autoimmunity and reproduction. Fertil Steril
  56. (2010). Liu Y-X: Testosterone induces redistribution of Forkhead box-3a and down regulation of growth and differentiation factor 9 messenger ribonucleic acid expression at early stage of mouse folliculogenesis. Endocrinology
  57. Live birth chances in women with extremely low serum anti-Müllerian hormone levels. Hum Reprod
  58. (2008). Macklon NS: Pregnancy complications in women with polycystic ovary syndrome. Semin Reprod Med
  59. (2001). Mc Allister JM: The biochemical basis for increased testosterone production in theca calls propagated from patients with polycystic ovary syndrome.
  60. (2010). McNeilly AS: Theca: the forgotten cell of the ovarian follicle. Reproduction
  61. (2006). MD: Basal and cycle androgen levels correlate with in vitro fertilization stimulation parameters but do not predict pregnancy outcome. Fertil Steril
  62. (2001). Mizunuma H: Effect of adrenal and ovarian androgens on type 4 follicles unresponsive to FSH in immature mice. Endocrinol
  63. (2002). Molecular biology of the androgen receptor.
  64. (2007). N: Age-specific levels of basal folliclestimulating hormone assessment of ovarian function. Obstet Gynecol
  65. (2011). N: Comparison of in vitro fertilsation success in patients with Polycystic ovary syndrome and tubal factor. Gynecol Endocrinol
  66. (2008). Ning G: Androgen receptor gene CAG(n) trinucleotide repeats polymorphism in Chinese women with polycystic ovary syndrome. Endocrine
  67. (2009). Ovarian function: a theory of relativity. Hum Reprod
  68. (2002). PA: Experimental evidence that changes in oocyte growth influence meiotic chromosome segregation. Hum Reprod
  69. (2004). Peterson EH: Effect of androgen levels on in vitro fertilization cycles. Fertil Steril
  70. Reddy BM: Androgen receptor CAG repeat polymorphism and epigenetic influence among the South Indian Women with polycystic ovary syndrome.
  71. (2010). RF: The use of mitochondrial nutrients to improve the outcome of infertility treatment in older patients. Fertil Steril
  72. (2010). Ribeiro MF: Age-related effects of DHEA on peripheral makers of oxidative stress. Cell Biochem Funct
  73. (2008). Rizzello F: Ovarian reserve. An NY Acad Sci
  74. (2009). Role of androgens in the treatment of patients with low ovarian response. Reprod Biomed Online
  75. (2006). Role of the N,N’-dimethylbiguanide metformin in the treatment of female prepuberal BALB/c mice hyperandrogenized with dehydroepiandrosterone. Reproduction
  76. (2007). S: Androgen receptor function in folliculogenesis and its clinical implication in premature ovarian failure. Trends Endocrinol Metab
  77. (2008). S: Androgen receptor gene CAG repeat length in women with metabolic syndrome. Gynecol Endocrinol
  78. (2010). S: Cumulative baby take-home rate among women with PCOS treated by IVF. Gynecol Endocrinol
  79. (1995). Seltman HJ: Increase in androgen: estrogen ratio specifically during low dose follicle-stimulating hormone therapy for polycystic ovary syndrome. Fertil Steril
  80. (2008). Serhal P: Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome. Arch Gynecol Obstet
  81. (1995). SG: Developmental regulation of androgen receptor in rat ovary.
  82. (2009). Soules MR, fauser BC: Ovarian aging: mechanisms and clinical consequences. Endocr Rev
  83. (2009). Sun Q-Y: Androgen receptor’s destiny in mammalian oocytes: a new hypothesis. Molec Hum Reprod
  84. (2010). Sun Q-Y: Demetyhylation of LHR in dehydroepiandrosterone-induced mouse model of polycystic ovary syndrome. Molec Hum Reprod
  85. (2008). Sun Q-Y: Testosterone potentially triggers meiotic resumption by activation of intra-oocyte SRC and MAPK in porcine oocytes. Biol Reprod
  86. (2008). Sun Qy: Testosterone potentially triggesr meiotic resumption by avtivation of intra-oocyte SRC and MAPK in porcine oocyte. Domest Anim Endocrinol
  87. (1980). Tenney DY: Effects of steroids on mouse oocyte maturation in vitro.
  88. (2011). Testosterone, not 5{alpha} dihydrotestosterone, stimulates LRH-1 leading to FSH-independnet expression of Cyp 19 and P450scc in granulosa cells. Mol Endocrinol
  89. (2009). Testosterone, sex hormone-binding globulin and free androgen index among adult women: chronological and ovarian aging. Hum Reprod
  90. (2002). The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation. Fertil Steril
  91. (2006). The mechanism involved in the action of metformin in regulating ovarian function in hyperandrogenized mice. Molec Hum Reprod
  92. (2009). Transdermal testosterone may improve ovarian response to gonadotrophins in low-repsonder IVF patients: a randomized, clinical trial. Hum Reprod
  93. (1995). Trounson AO: The effect of testosterone on the maturation and development capacity of murine oocytes in vitro. Hum Reprod
  94. (2007). Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
  95. (2006). Vanrell JA: Pretreatment with transdermal testosterone may improve ovarian response to gonadothrophins
  96. (2010). Voorhis BJ: Effects of exogenous testosterone supplementation in gonadotrophin stimulated cycles. Hum Reprod
  97. (2007). Voorhis BJ: Testosterone patch improves ovarian follicular response to gonadotrophins in a patient with Kallmann’s syndrome: a case report. Hum Reprod
  98. Weghofer A: Hormonal contraception prior to in vitro fertilization (IVF) adversely affects functional ovarian reserve and oocyte yields. Fertil Steril ,
  99. (2011). Z-J: Association of basal serum testosterone levels with ovarian response and in vitro fertilization outcome. Reprod Biol Endocrin